Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

UK trials test effectiveness of atropine, contact lenses and spectacle lenses in managing myopia

Aston University is recruiting children between the ages of six and 15 to take part in myopia research

young child reading
Pixabay/StockSnap
UK studies will investigate the effectiveness of low dose atropine eye drops, contact lenses and spectacle lenses in managing myopia.

Aston University is recruiting children between the ages of six and 15 to take part in the clinical studies, which will involve a range of different interventions.

The research is being done in partnership with industry, including CooperVision, and in collaboration with the Universities of Queens, Ulster, Glasgow Caledonian, Anglia Ruskin, Waterloo and TU Dublin. One of the trials is funded by the National Institute for Health Research.

Lead researcher at Aston University, Dr Nicola Logan, shared that myopia is often considered benign because blurred vision is frequently easily corrected through glasses, contact lenses or refractive surgery.

“Higher levels of myopia are associated with increased risk of pathological complications, but it is important to note that there is no safe level of myopia. Even low levels of myopia increase the risk of sight-threatening eye conditions,” she said.

“We are at an exciting time whereby we now have interventions based on research evidence that can be used in clinical practice that will help to slow down the rate of progression of myopia,” Logan observed.

Researchers are aiming to recruit around 200 children across three trials by the end of 2021.

Parents or guardians of children with myopia who are interested in finding out more about the trial can contact the research team by email.